Estimating #measles susceptibility and #transmission #patterns in #Italy: an epidemiological assessment

Summary

Background

Identifying measles transmission patterns and the most susceptible populations is crucial for anticipating and preventing outbreaks. The aim of this study was to assess the current epidemiology of measles in Italy to provide key metrics to anticipate and prevent future transmission risks.

Methods

In this epidemiological assessment study, we analysed measles epidemiological data from the National Integrated Measles and Rubella Surveillance System coordinated by the Department of Infectious Diseases of the Istituto Superiore di Sanità in Italy from Jan 1, 2013, to Dec 31, 2022. We analysed individual case records to assess the proportion of transmission that occurred in different settings; we also used pairs of measles cases to estimate the generation time and the proportion of transmission episodes between population groups defined by age and vaccination status. All suspected cases meeting the measles case definition were included in our analysis. Data, complemented with 2023 and 2024 incidence records, were used in a catalytic model to estimate the age-specific proportion of individuals susceptible to measles and the effective reproduction number (Re) in Italy in 2025 at the national level and for each Italian region.

Findings

During the study period, 14 946 measles cases (7426 females and 7520 males) were reported to the National Integrated Measles and Rubella Surveillance System. The mean generation time estimated from 795 measles infection episodes was 11·7 days (95% credible interval 11·3–12·0). 707 (88·9% [bootstrap 95% CI 86·8–91·1]) of 795 infection episodes originated in unvaccinated individuals, 265 (33·3% [30·1–36·7]) of 795 infection episodes involved individuals aged 20–39 years, and only 12 (8·5% [4·3–13·5]) of 141 transmission episodes with available information on setting were linked to school contacts. We estimated that, in 2025, 9·2% (95% prediction interval 8·9–9·3) of the Italian population remains susceptible to measles, including 11·8% (11·8–11·8) of individuals younger than 20 years. Despite marked geographical heterogeneities, immunity gaps among individuals aged 20–40 years (ie, those born in the 1980s and 1990s) were consistently observed across all regions. The average Re estimated for 2025 ranged from 1·31 to 1·78 across regions, consistent with reproduction numbers associated with national epidemics and local outbreaks between 2013 and 2019. Higher Re values were found in regions with a large fraction of susceptible adults (eg, Emilia-Romagna 1·78 [1·34–2·27]) or more than 15% susceptible individuals younger than 20 years (eg, South Tyrol 1·53 [1·11—2·02]).

Interpretation

Unvaccinated adults contribute substantially to measles transmission in Italy. Heterogeneous immunity gaps exist across regions, with some regions showing persistently low vaccine uptake in children and other regions showing a high proportion of susceptible adults. These results emphasise the need for tailored vaccination strategies, including catch-up campaigns for adults. By integrating routine surveillance data with modelling techniques, this study presents a resource-efficient approach to quantifying immunity and transmission risks, providing a scalable framework for countries aiming to refine their immunisation policies.

Funding

NextGenerationEU-MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases.

Source: Lancet Infectious Diseases, https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00293-2/abstract?rss=yes

____

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...

ETIDIOH - NEW

Search This Blog